These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9778860)

  • 1. [Costs of interventions for patients with chronic renal disease].
    Arredondo A; Rangel R; de Icaza E
    Rev Saude Publica; 1998 Jun; 32(3):255-61. PubMed ID: 9778860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of economic impact between the modality of renal replacement therapy.
    Gouveia DSES; Bignelli AT; Hokazono SR; Danucalov I; Siemens TA; Meyer F; Santos LS; Martins ZCL; Mierzwa TC; Furquim R
    J Bras Nefrol; 2017; 39(2):162-171. PubMed ID: 28489179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.
    Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A
    Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
    Shih YC; Guo A; Just PM; Mujais S
    Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of Dialysis Therapy by Modality in Manitoba.
    Beaudry A; Ferguson TW; Rigatto C; Tangri N; Dumanski S; Komenda P
    Clin J Am Soc Nephrol; 2018 Aug; 13(8):1197-1203. PubMed ID: 30021819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs of chronic dialysis in a public hospital: myths and realities].
    Lamas J; Alonso M; Saavedra J; García-Trío G; Rionda M; Ameijeiras M
    Nefrologia; 2001; 21(3):283-94. PubMed ID: 11471309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
    Zhang H; Zhang C; Zhu S; Ye H; Zhang D
    BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of renal replacement therapies in Finland.
    Salonen T; Reina T; Oksa H; Sintonen H; Pasternack A
    Am J Kidney Dis; 2003 Dec; 42(6):1228-38. PubMed ID: 14655195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodialysis versus peritoneal dialysis, which is cost-effective?
    Atapour A; Eshaghian A; Taheri D; Dolatkhah S
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):962-5. PubMed ID: 26354569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].
    Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H
    Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data.
    Mohnen SM; van Oosten MJM; Los J; Leegte MJH; Jager KJ; Hemmelder MH; Logtenberg SJJ; Stel VS; Hakkaart-van Roijen L; de Wit GA
    PLoS One; 2019; 14(8):e0220800. PubMed ID: 31415578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of renal dialysis in a UK setting--a multicentre study.
    Baboolal K; McEwan P; Sondhi S; Spiewanowski P; Wechowski J; Wilson K
    Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-emptive renal transplantation.
    Hakim NS; Benedetti E; Payne WD; Gruessner R; Gores P; Sutherland DE; Najarian JS; Matas AJ
    Int Surg; 1998; 83(4):330-2. PubMed ID: 10096754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of substitutive renal therapies in children.
    Camargo MFC; Barbosa KS; Fetter SK; Bastos A; Feltran LS; Koch-Nogueira PC
    J Pediatr (Rio J); 2018; 94(1):93-99. PubMed ID: 28750890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hemodialysis and peritoneal dialysis--a cost-utility analysis.
    Sennfält K; Magnusson M; Carlsson P
    Perit Dial Int; 2002; 22(1):39-47. PubMed ID: 11929142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.